Institutional investors purchased a net $103.2 thousand shares of TXMD during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 80.83% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VOYA INVESTMENT MANAGEMENT CO. L... Bought 2.2 Million shares of TherapeuticsMD Inc
T. ROWE PRICE ASSOCIATES, INC. Bought 1.9 Million shares of TherapeuticsMD Inc
NEWTYN MANAGEMENT LLC Bought 1.4 Million shares of TherapeuticsMD Inc